Bank of America’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $130K | Sell |
2,751
-88,423
| -97% | -$4.17M | ﹤0.01% | 5415 |
|
|
2025
Q1 | $3.56M | Buy |
91,174
+45,634
| +100% | +$1.78M | ﹤0.01% | 3500 |
|
|
2024
Q4 | $2.47M | Sell |
45,540
-76,559
| -63% | -$4.15M | ﹤0.01% | 3596 |
|
|
2024
Q3 | $6.16M | Buy |
122,099
+68,063
| +126% | +$3.43M | ﹤0.01% | 3021 |
|
|
2024
Q2 | $2.38M | Buy |
54,036
+33,177
| +159% | +$1.46M | ﹤0.01% | 3672 |
|
|
2024
Q1 | $1.05M | Sell |
20,859
-17,326
| -45% | -$870K | ﹤0.01% | 4141 |
|
|
2023
Q4 | $2.31M | Buy |
38,185
+1,832
| +5% | +$111K | ﹤0.01% | 3521 |
|
|
2023
Q3 | $2.07M | Sell |
36,353
-6,304
| -15% | -$359K | ﹤0.01% | 3523 |
|
|
2023
Q2 | $2.18M | Buy |
42,657
+32,377
| +315% | +$1.65M | ﹤0.01% | 3497 |
|
|
2023
Q1 | $220K | Buy |
10,280
+2,380
| +30% | +$50.9K | ﹤0.01% | 5102 |
|
|
2022
Q4 | $83K | Buy |
+7,900
| New | +$83K | ﹤0.01% | 5546 |
|